Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Assets Average: 2022-2025

Historic Assets Average for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $470.2 million.

  • Centessa Pharmaceuticals' Assets Average fell 6.76% to $470.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.2 million, marking a year-over-year decrease of 6.76%. This contributed to the annual value of $468.5 million for FY2024, which is 16.47% up from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Assets Average is $470.2 million, which was down 7.80% from $510.0 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Assets Average high stood at $593.3 million for Q4 2024, and its period low was $344.2 million during Q1 2024.
  • Its 3-year average for Assets Average is $446.7 million, with a median of $424.1 million in 2023.
  • Its Assets Average has fluctuated over the past 5 years, first declined by 27.78% in 2023, then spiked by 60.86% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' Assets Average (Quarterly) stood at $461.8 million in 2022, then fell by 20.14% to $368.8 million in 2023, then surged by 60.86% to $593.3 million in 2024, then dropped by 6.76% to $470.2 million in 2025.
  • Its Assets Average was $470.2 million in Q3 2025, compared to $510.0 million in Q2 2025 and $552.3 million in Q1 2025.